Halberd Corp HALB

Halberd Corporation is a holding company. The Company is engaged in the acquisition vehicle for established businesses. It is also developing treatments for neurodegenerative diseases, such as post-traumatic stress disorder/chronic traumatic encephalopathy (PTSD/ CTE), Alzheimer’s disease and Parkinson’s disease. It has two issued patents and four provisional patent applications related to the extracorporeal treatment of blood-borne diseases and cerebrospinal fluid related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other viruses. Its Sequential Dialysis Technique is a methodology that physically removes the pathophysiologic basis of the disease, eliminating it without side effects. The Company’s wholly owned subsidiary is Alaric Corporation.

OTCPK:HALB - Post by User

Halberd Corp

<< Previous

Bullboard Posts

Next >>

Post by Williaminvestoron Jan 24, 2023 9:48am

37 Views

Post# 35242006

Halberd Agrees to Animal Testing at Mississippi State Univer

#BreakingNews Halberd $HALB Agrees to Animal Testing at Mississippi State University #MSU

Halberd Agrees to Animal Testing at Mississippi State University

JACKSON CENTER, PA January 24, 2023 Halberd Corporation's (OTC: HALB) has agreed to conduct animal testing at Mississippi State University's (MSU) animal testing laboratory. Read more

https://finance.yahoo.com/news/halberd-agrees-animal-testing-mississippi-130000516.html

<< Previous

Bullboard Posts

Next >>

Bitcoin company adds convenience of modern banking